Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

KPRX US Equity

Kiora Pharmaceuticals IncHealth Care · Pharmaceutical Preparations · CIK 1372514 · FY ends Dec 31
$2.60
+0.01 (+0.39%)
USD · as of 2026-08-19 · marketstack
2 8-K filings · 0 13D · 3 13G
DateEventWhat happened / filerSource
2026-08-198-K 7.01Regulation FD disclosuresec.gov ↗
2026-08-198-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by ADAR1 Capital Management, LLCsec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Nantahala Capital Management, LLCsec.gov ↗
2026-08-1013GSchedule 13G filed — ≥5% beneficial owner (passive) · by PERCEPTIVE ADVISORS LLCsec.gov ↗
2026-08-078-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-08-07

Every row is a filed document, checked against its EDGAR index.